Sareum Share Discussion Threads

[thedarkhalf] 08/7/2022 10:24

They are mostly spastics here gekko, no cure for that. At least you're in good company. Just not a good company. (That will go over their heads.)

[spacedust] 08/7/2022 09:35

I got out as soon as I saw consolidation. Put my proceeds in big ones rolls Royce. Which gone down the pan too but confident it'll be 100 plus

[gekko2023] 08/7/2022 09:30

Even Froth2 appears to have bailed on the good ship Faileum...wonder how much longer the jolly old BOD think they can get away with failure after failure to deliver anything resembling any kind of success. Even our own broker note shows a derisory "upside" of 60% above current share price! Is that it?! Our "best in class" compounds make us worth nothing more than £200m?! Shame...xxx

[spacedust] 08/7/2022 08:53

I did say that consolidation is the dearh of the share price

[criticalthinker1] 07/7/2022 20:54

So I called right on EUA and took 35% profit in 24hrs today on half my purchase. Reminded individuals of pyc last night and they RNSd today re increasing staffing with noteable backgrounds. Market will catch up with the bigger picture in time.
Keep it in the family type scenario!
Results published by GSK tomorrow.
Tyk tok.
The shake post consolidation was noteable. Some serious buying but token sells to keep share price down.
Latest Edison report. Oh my!
I'm not buying the PH thing.
Await GSK update tomorrow.
And a bonus I got some more cheap shares.
GLA.

[gekko2023] 07/7/2022 17:45

So, that's it then, our house brokers have said our share price only has 60% upside. Quite sobering when ON LSE they speak about share price of 100 a share or sunmit! Sareum, healing the world etc..xx

[gekko2023] 07/7/2022 11:30

Peel hunt reckon we have 60% upside potential to share price?! Frogth2 will be in tears...they mean 600000% surely?! Lol...

[horridhenry] 07/7/2022 08:37

Stop stalking Emma Walmsley. She doesn't have a clue what 737 is

Last nights posts pretty much confirm that you are a deranged nutcase. No one in their right mind will take any notice of your ridiculous posting.

Have some more Gin

[criticalthinker1] 06/7/2022 21:00

Emma Walmsley.

I further suspect that Physiomics are working on our behalf in the background as they have previously.

[criticalthinker1] 06/7/2022 18:55

What I'm expecting
Update. GSK split confirmed. Tick.
Then...
We appreciate momelotinib is at ph3 and ready for market 2023 but we are addressing other promising attained pipeline drugs inline with our strategy alongside satisfying Elliot Holdings as a major holder.

Requirements and intentions to progress a pipeline drug/s via one of our acquisition is Sierra Oncology which one of them has gained ph2 status and inhuman trials and will be utilised with other companies under our licence protocol.
Please note we are under ndas whilst the formalities are agreed upon in order to insure we are dealing with the relevant parties in order to gain best potential results and investment return.
Regards Emma

That's my take.

[criticalthinker1] 05/7/2022 22:10

Aah
Galapagos continues fibrosis pipeline build-out with Evotec deal
By Nick Paul Taylor
Feb 7, 2019 02:05pm
fibrosisEuroBiotech ReportEvotecGalapagos
Share
Galapagos
Galapagos is paying an upfront fee and committing to milestones and royalties to secure global rights to the drug. (Galapagos)
Galapagos has secured the global rights to a preclinical fibrotic disease program from Evotec. The small molecule will slot into the growing fibrosis pipeline Galapagos is building through internal R&D and deals.

Belgium-based Galapagos indicated its interest in striking deals to bolster its fibrosis pipeline last month when it struck a deal to collaborate on a novel idiopathic pulmonary fibrosis (IPF) target with Fibrocor Therapeutics. Fibrocor worked with CRO Evotec to generate the data package that attracted the interest of Galapagos.

For its latest deal, Galapagos has gone direct to Evotec, which discovers drugs as well as working on assets owned by other companies. Evotec’s in-house activities have yielded a small molecule fibrosis drug that Galapagos sees as a good fit for its pipeline.

Read into it what you want.
Points.
Galapagos and sareum link up
Belgium!! You know if you know
Momelotinib...myelofibrosis
Sierra oncology takeover by GSK

1st July 2022 evotec acquired GSK Verona site
All a coincidence
Nothing to see here

[gekko2023] 05/7/2022 19:08

Hi CriticallyWhatever...

No...

Love, Gekko...xxx

[criticalthinker1] 05/7/2022 19:05

Hi. Critical whatever here.
Serious question.
Is there any link between Sareum, Galapagos and Transgene re solid tumors?
I appreciate there are links to Galapagos with Sareum, but any with all three?
Appreciate any constructive response.
Many thanks in advance.